CFO Jason O'Byrne resigns effective Sept 27; Ryan Fischesser named principal accounting officer

Caribou Biosciences, Inc.

Jason O'Byrne resigns as CFO effective Sept 27, 2024, to pursue other opportunity; no disagreement with company.
Company has initiated search for new CFO.
Ryan Fischesser, VP Finance and Controller, will assume principal accounting officer role Sept 27.
Fischesser previously served as principal accounting officer from IPO through Dec 2022.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Jason O'Byrne

Chief Financial Officer

CRBU · Caribou Biosciences, Inc.

Effective: 2024-09-27
Filed: September 3, 2024, 7:59 PM ET

On September 1, 2024, Jason O’Byrne, the Chief Financial Officer of Caribou Biosciences, Inc. (the “Company”), informed the Company of his intent to resign from his position, effective September 27, 2024, to pursue another opportunity.

Appointed

Ryan Fischesser

principal accounting officer

CRBU · Caribou Biosciences, Inc.

Effective: 2024-09-27
Filed: September 3, 2024, 7:59 PM ET

The Company intends to appoint Ryan Fischesser, the Company’s current Vice President of Finance and Controller, to assume the role of the Company’s principal accounting officer, effective as of the close of business on September 27, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jason O'Byrne resigned as Chief Financial Officer at Caribou Biosciences, Inc..

Action: resigned
Role: Chief Financial Officer

Exact text from the filing

On September 1, 2024, Jason O’Byrne, the Chief Financial Officer of Caribou Biosciences, Inc. (the “Company”), informed the Company of his intent to resign from his position, effective September 27, 2024, to pursue another opportunity.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Ryan Fischesser was appointed as principal accounting officer at Caribou Biosciences, Inc..

Action: appointed
Role: principal accounting officer

Exact text from the filing

The Company intends to appoint Ryan Fischesser, the Company’s current Vice President of Finance and Controller, to assume the role of the Company’s principal accounting officer, effective as of the close of business on September 27, 2024.

View on SEC.gov

Caribou Biosciences, Inc. filing history →

Source: SEC EDGAR

accession 0001619856-24-000071

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.